The Department of Neurology congratulations three staff members for being awarded the Neurology Staff Employees of the Quarter for Q3 FY24. For the first time, the department accepted nominations for three award categories in an effort to highlight the dedication and accomplishments of our staff members — clinical, research and administration. Clinical Staff Employee of […]
The pharmaceutical manufacturer Eli Lilly announced on Wednesday that its obesity drug tirzepatide, or Zepbound, provided considerable relief to overweight or obese people who had obstructive sleep apnea, or episodes of stopped breathing during sleep.
Nearly all adults with Down syndrome will develop evidence of Alzheimer’s disease by late middle age. A new study by researchers at Washington University School of Medicine in St. Louis shows that the disease both starts earlier and moves faster in people with Down syndrome, a finding that may have important implications for the treatment […]
A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis type 1 (NF1), according to a study by researchers at Washington University School of Medicine in St. Louis. NF1 is a genetic condition that causes tumors to grow on nerves throughout the body, including the […]
The new exhibit, stretching nearly 50 yards along a prominent wall on the Medical Campus, demands attention. Historical photographs depict the experiences of Black individuals – health-care workers and other employees, patients and students – at Washington University School of Medicine and its partner hospitals.
Hypoglossal nerve stimulation reduced obstructive sleep apnea severity; however, this outcome was less likely among those with higher BMIs and those who slept in supine position, according to study results. “Physicians can take both this new information about BMI and sleeping on your back vs. your side into consideration when counseling patients with OSA,” Eric C. Landsness, […]
An implant for obstructive sleep apnea — a serious sleep malady in which breathing stops for 10 seconds to two minutes many times an hour each night — works best in people who are overweight but not severely obese, a new study found. To qualify for the device, called a hypoglossal nerve stimulator, a person over 18 diagnosed with […]
A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up to 40, a weight range generally described as severely obese. A healthy BMI ranges from 18.5 to 24.9.
Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation of Alzheimer’s drugs — the first proven to change the course of the disease — work by tagging amyloid for […]
Two studies of commercially available biomarkers of synucleinopathies have reached sharply different conclusions on their reliability, according to the findings from two abstracts presented at the AAN Annual Meeting, held in Denver in April.